Axon Enterprise, Inc $AXON Shares Acquired by 11 Capital Partners LP

11 Capital Partners LP raised its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 56.9% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20,095 shares of the biotechnology company’s stock after buying an additional 7,287 shares during the quarter. Axon Enterprise comprises 4.1% of 11 Capital Partners LP’s portfolio, making the stock its 16th largest position. 11 Capital Partners LP’s holdings in Axon Enterprise were worth $14,421,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the company. Stone House Investment Management LLC acquired a new stake in shares of Axon Enterprise in the 3rd quarter worth about $29,000. New Millennium Group LLC acquired a new position in Axon Enterprise during the 3rd quarter valued at about $29,000. Root Financial Partners LLC bought a new position in Axon Enterprise in the 3rd quarter worth about $34,000. Darwin Wealth Management LLC acquired a new stake in shares of Axon Enterprise in the second quarter valued at approximately $37,000. Finally, Elevation Point Wealth Partners LLC acquired a new stake in shares of Axon Enterprise in the second quarter valued at approximately $56,000. Institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on AXON. Piper Sandler reduced their price target on Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating for the company in a research report on Wednesday, February 25th. Northcoast Research upgraded shares of Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 target price for the company in a research report on Tuesday, January 6th. Wall Street Zen upgraded shares of Axon Enterprise from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. Needham & Company LLC decreased their price target on Axon Enterprise from $870.00 to $600.00 and set a “buy” rating for the company in a research note on Friday, February 20th. Finally, Morgan Stanley lowered their price target on Axon Enterprise from $713.00 to $675.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 25th. Sixteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $762.93.

Axon Enterprise Trading Down 3.5%

Shares of NASDAQ AXON opened at $499.40 on Friday. The company has a quick ratio of 2.29, a current ratio of 2.53 and a debt-to-equity ratio of 0.53. Axon Enterprise, Inc has a 12 month low of $396.41 and a 12 month high of $885.91. The company has a market cap of $40.15 billion, a price-to-earnings ratio of 328.55, a P/E/G ratio of 11.05 and a beta of 1.46. The business has a fifty day simple moving average of $532.43 and a 200-day simple moving average of $612.29.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 EPS for the quarter, topping the consensus estimate of $1.60 by $0.55. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The company had revenue of $796.72 million during the quarter, compared to analysts’ expectations of $755.29 million. During the same period last year, the company posted $2.08 earnings per share. The business’s revenue for the quarter was up 38.5% on a year-over-year basis. Sell-side analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Insider Activity

In related news, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $500.24, for a total transaction of $5,002,400.00. Following the transaction, the chief executive officer directly owned 3,090,997 shares of the company’s stock, valued at approximately $1,546,240,339.28. The trade was a 0.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Isaiah Fields sold 2,000 shares of the stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $535.01, for a total value of $1,070,020.00. Following the completion of the sale, the insider directly owned 55,588 shares of the company’s stock, valued at approximately $29,740,135.88. This represents a 3.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 24,634 shares of company stock worth $13,803,095. 4.40% of the stock is owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.